News
GRFS
7.74
-0.51%
-0.04
EUROPE RESEARCH ROUNDUP-Greencore, UCB, Unilever
Reuters · 23h ago
Weekly Report: what happened at GRFS last week (0715-0719)?
Weekly Report · 4d ago
Undercovered Dozen: Spirit Airlines, HubSpot, Cigna, First Quantum Minerals +
Home Stock Ideas Quick Picks & Lists Undercovered Dozen: Spirit Airlines, HubSpot, Cigna, First Quantum Minerals. We share 12 ideas published last week focused on stocks with less coverage on Seeking Alpha. The 'Undercovered' Dozen series highlights undercovered stocks on our platform. Rubrik, Inc. Is a compelling buy post-IPO. Polestar Automotive Holding is a sell. HubSpot faces volatility post-Google acquisition plans.
Seeking Alpha · 07/19 18:15
Grifols: Going Private? Brookfield On The Scene
Spanish pharmaceutical company Grifols faces challenges with high debt levels and difficulty in refinancing. Brookfield Asset Management is in talks with majority shareholders to potentially privatize the company. Moody's downgraded the corporate rating of the company to junk status. The company's cash flow recovery is not expected to be good in Q2.
Seeking Alpha · 07/16 10:59
Grifols: Stay On The Sidelines
Seeking Alpha · 07/16 09:00
Weekly Report: what happened at GRFS last week (0708-0712)?
Weekly Report · 07/15 09:23
Grifols board to back a potential go-private deal
Healthcare Grifols board to back a potential go-private deal involving its founding family and asset manager, Brookfield Fund. Shares of the Spanish plasma therapeutics company surged this week after a preliminary offer from the Grifol's family and Brookfield was announced. The company's board of directors unanimously adopted measures to facilitate the deal.
Seeking Alpha · 07/12 17:35
Grifols Board Votes To Grant Brookfield Access To Information For Potential Takeover Bid; Establishes Independent Committee To Monitor Transaction Progress And Present Proposals To Board
Benzinga · 07/12 16:54
GRIFOLS - TO DELEGATE TO TRANSACTION COMMITTEE WORK FOR ENGAGEMENT OF FINANCIAL ADVISORS IN CONTEXT OF TRANSACTION
Reuters · 07/12 16:40
GRIFOLS - IN RELATION TO POSSIBLE TRANSACTION WITH BROOKFIELD, TO SET UP COMMITTEE OF BOARD OF DIRECTORS COMPOSED EXCLUSIVELY OF INDEPENDENT DIRECTORS
Reuters · 07/12 16:40
Top Stock Gainers Today – LNTH, APGE, and More
TipRanks · 07/10 18:30
UPDATE 1-Europe's STOXX 600 dips ahead of Powell testimony; Indivior sinks
Reuters · 07/09 08:16
LIVE MARKETS-Busy beginning in Britain
European shares are a touch lower in the first hour of trading. Stoxx 600 down 0.2%, U.S. Futures up around 0.3%. FTSE 100 up 0.25% in the opening minutes of trading in Britain. Oil and gas giant BP's shares down 3.5% after warning on profits. Indivior down 38%, biggest faller on the STOXX 600, down 38% in first hour.
Reuters · 07/09 08:13
LIVE MARKETS-Profit warnings and take-privates
European markets open down on profit warnings and take-privates. U.S. Federal Reserve Chair Jerome Powell's appearance before Congress. Biggest story for European markets will be single stocks. BP and Eni have both warned of lower profits for the second quarter of 2014.
Reuters · 07/09 06:51
RPT-UPDATE 3-Grifols says founding family, Brookfield looking to delist drugmaker
Grifols says founding family, Brookfield looking to delist drugmaker Grifols GRLS.MC. The founding family and Canadian fund Brookfield have agreed to evaluate a possible joint takeover bid. Brookfield says it has the intent to delisted the Spanish drugmaker. The deal could be worth 5.5 billion euros.
Reuters · 07/09 05:00
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Arhaus, Inc. (NASDAQ:ARHS) fell 7.9% to $14.55 on Monday. Morphic Holding, Inc (MORF) shares jumped 75% after Eli Lilly agreed to buy the company for $57 per share in cash. Zapp Electric Vehicles Group Limited shares jumped 71% after jumping around 50% on Friday. Paramount Corporation shares rose 3.8% in a $28 billion merger deal with Intel Corporation.
Benzinga · 07/08 17:16
GRFS Stock Alert: Grifols Pops 20% on Takeover Interest
Grifols (NASDAQ:GRFS) stock is up 19.8% as of Monday afternoon. The founding family of the company is considering a takeover offer that would see it go private. More than 6.3 million shares of GRFS stock are changing hands. The Grifols family is working with Brookfield on the takeover offer.
Investorplace · 07/08 16:36
Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why
Brookfield Capital has engaged in preliminary discussions with Grifols SA to delist the company's shares from the Spanish stock exchanges and NASDAQ. The company has signed an exclusivity agreement with the shareholders to explore the possibility of delisting. Grifol's shares are down 2.7% in 2014.
Benzinga · 07/08 15:16
M&A News: Grifols Shoots Up Amid Takeover Bid
TipRanks · 07/08 14:26
Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday
Corning shares jumped 9.4% to $42.05 on Monday. The company increased its second-quarter core sales guidance. Morphic Holding, Inc. Shares gained 75% after Eli Lilly agreed to buy the company for $57 per share in cash. Shares of Corning rose sharply after the Dow Jones index surged around 200 points.
Benzinga · 07/08 14:19
More
Webull provides a variety of real-time GRFS stock news. You can receive the latest news about Grifols S A through multiple platforms. This information may help you make smarter investment decisions.
About GRFS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.